Inflammatory breast cancer (IBC) tumors are characterized by diffuse, clusters of cells found in dermal tissue and lymphatic vessels, known as tumor emboli.
This study investigates the interaction between tumor emboli and the tumor immune microenvironment (TiME) that can foster survival signaling.
